Patents by Inventor Korbinian Brand

Korbinian Brand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7955623
    Abstract: The present invention refers to a pharmaceutical preparation for treating inflammatory diseases and microbial infections comprising a pharmaceutically effective amount of ozone and at least one monomeric amino acid having an oxidation-sensitive side chain, or at least one ozonized monomeric amino acid having an oxidation-sensitive side chain. Also described is the use of a preparation as described before for providing a medicament for treating inflammatory diseases, microbial infections and for immune modulation. The pharmaceutical preparation according to the invention is particularly useful in the treatment of oral inflammations.
    Type: Grant
    Filed: April 22, 2008
    Date of Patent: June 7, 2011
    Inventors: Karin Christine Huth, Korbinian Brand
  • Publication number: 20090263498
    Abstract: The present invention refers to a pharmaceutical preparation for treating inflammatory diseases and microbial infections comprising a pharmaceutically effective amount of ozone and at least one monomeric amino acid having an oxidation-sensitive side chain, or at least one ozonized monomeric amino acid having an oxidation-sensitive side chain. Also described is the use of a preparation as described before for providing a medicament for treating inflammatory diseases, microbial infections and for immune modulation. The pharmaceutical preparation according to the invention is particularly useful in the treatment of oral inflammations.
    Type: Application
    Filed: April 22, 2008
    Publication date: October 22, 2009
    Inventors: Karin Christine Huth, Korbinian Brand
  • Publication number: 20040241166
    Abstract: The invention relates to the use of an IKK-&bgr; inhibitor for the production of a medicament for the treatment or prevention of atheroscieroses. A screening method for the discovery of IKK-&bgr; inhibitors in endothelial cells is also disclosed. The method involves the contacting of a potential inhibitor with activated endothelial cells and a determination of the secretion of MCP-1 from the endothelial cells.
    Type: Application
    Filed: July 6, 2004
    Publication date: December 2, 2004
    Inventors: Martin Ungerer, Korbinian Brand, Meinrad Gawaz